The Motley Fool

TSX:GUD (KNIGHT THERAPEUTICS INC)

$6.31 $-0.18 (-0.03) Friday, April 3, 2020 at 4:00:00 p.m. Eastern Daylight Time

About

Last updated Apr 03, 2020, 04:00:00pm EDT
Current Price $6.31
Today's Change $-0.18 (-2.8%)
Close Price $6.31
Open Price $6.52
Bid $6.30
Ask $6.41
Day Range $6.27 - $6.64
Year Range $4.73 - $8.12
Volume 668,182
Average Volume 408,584
Market Cap $854,258,571.00
EPS (ttm) $0.10

Related Articles

TFSA Investors: 2 Growth Stocks I’m Buying If the Market Selloff Gets Worse

Ambrose O'Callaghan | March 8, 2020

During turbulent economic times, investors usually want to dial back risk and retreat to stable income vehicles. However, recent history has shown us how... More »

Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!

Nikhil Kumar | May 24, 2019

Does the genius of CEO Jonathan Goodman of Knight Therapeutics Inc. (TSX:GUD) come for free? More »

Growth Investors: This Stock Could Easily Turn $10,000 Into $100,000

Nelson Smith | April 2, 2019

Jonathan Goodman and Knight Therapeutics Inc. (TSX:GUD) could be the market's next great growth story. Are you willing to let this opportunity pass? More »

Revealed: 5 Top Growth Picks From This Award-Winning Mutual Fund

Nelson Smith | November 5, 2018

One of Canada's best mutual funds is investing in small-cap growth companies like Freshii Inc. (TSX:FRII), Aritzia Inc. (TSX:ATZ), and Sierra Wireless, Inc. (TSX:SW)(NASDAQ:SWIR).... More »

5 Reasons Why This Pharma Stock Is Poised for Takeoff

Kenrick Vassall | August 4, 2018

Knight Therapeutics Inc. (TSX:GUD) has an effective low-risk strategy combined with one of the best balance sheets in the industry. More »

Can Knight Therapeutics Inc. Repeat the Success of Paladin Labs?

Karen Thomas, MSc, CFA | May 18, 2017

Knight Therapeutics Inc. (TSX:GUD) offers investors exposure to the lucrative specialty pharmaceutical market. More »